These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6093767)

  • 1. The effect of low-density lipoproteins on the synthesis of cyclic nucleotides induced by prostacyclin in isolated platelets.
    Bruckdorfer KR; Buckley S; Hassall DG
    Biochem J; 1984 Oct; 223(1):189-96. PubMed ID: 6093767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The aggregation of isolated human platelets in the presence of lipoproteins and prostacyclin.
    Hassall DG; Owen JS; Bruckdorfer KR
    Biochem J; 1983 Oct; 216(1):43-9. PubMed ID: 6360159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refractoriness of platelets to prostaglandins after infusion in rabbits.
    Bertelé V; Stemerman M; Schafer A; Adelman B; Smith M; Fuhro R; Salzman E
    J Lab Clin Med; 1985 Nov; 106(5):551-61. PubMed ID: 2997353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of heparin on prostacyclin binding and platelet adenylate cyclase activity stimulated by iloprost and forskolin.
    Jaschonek K; Faul C; Daiss W; Weisenberger H
    Prostaglandins Leukot Med; 1986 Oct; 24(2-3):199-206. PubMed ID: 2432618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced platelet aggregation by effects of pentoxifylline on vascular prostacyclin isomerase and platelet cyclic AMP.
    Weithmann KU
    Gen Pharmacol; 1983; 14(1):161-2. PubMed ID: 6298055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of cyclic AMP in the inhibition of human platelet aggregation by quercetin, a flavonoid that potentiates the effect of prostacyclin.
    Beretz A; Stierle A; Anton R; Cazenave JP
    Biochem Pharmacol; 1982 Nov; 31(22):3597-600. PubMed ID: 6295405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel mechanism of heterologous desensitization of adenylate cyclase: prostaglandins bind with different affinities to both stimulatory and inhibitory receptors on platelets.
    Ashby B
    Mol Pharmacol; 1990 Jul; 38(1):46-53. PubMed ID: 1695318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The increased sensitivity of platelets to prostacyclin in marathon runners.
    Dix CJ; Hassall DG; Bruckdorfer KR
    Thromb Haemost; 1984 Jul; 51(3):385-7. PubMed ID: 6093280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostacyclin inhibits mobilisation of fibrinogen-binding sites on human ADP- and thrombin-treated platelets.
    Hawiger J; Parkinson S; Timmons S
    Nature; 1980 Jan; 283(5743):195-7. PubMed ID: 6985716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of aggregation and stimulation of cyclic AMP generation in intact human platelets by the diterpene forskolin.
    Siegl AM; Daly JW; Smith JB
    Mol Pharmacol; 1982 May; 21(3):680-7. PubMed ID: 6287202
    [No Abstract]   [Full Text] [Related]  

  • 11. Forskolin alters sensitivity of the cAMP-generating system to stimulatory as well as to inhibitory agonists. A study with intact human platelets and guinea pig myometrium.
    Mokhtari A; Do Khac L; Harbon S
    Eur J Biochem; 1988 Sep; 176(1):131-7. PubMed ID: 2843365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of activation of protein kinase C on the agonist-induced stimulation and inhibition of cyclic AMP formation in intact human platelets.
    Williams KA; Murphy W; Haslam RJ
    Biochem J; 1987 May; 243(3):667-78. PubMed ID: 2444206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Iloprost, Cicaprost and prostacyclin effects on cyclic AMP metabolism in intact platelets.
    Ashby B
    Prostaglandins; 1992 Mar; 43(3):255-61. PubMed ID: 1378640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azelastine potentiates the prostaglandin-induced increase of cyclic AMP content in human platelets and in guinea-pig alveolar macrophages.
    Hatmi M; Havet N; Vargaftig BB; Bachelet M
    Prostaglandins; 1992 May; 43(5):457-72. PubMed ID: 1374922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochemical localization of adenylate cyclase in the dense tubule system of human blood platelets stimulated by forskolin, prostacyclin and prostaglandin D2.
    Cutler LS; Christian CP; Feinstein MB
    Biochim Biophys Acta; 1985 Jun; 845(3):403-10. PubMed ID: 3890960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of the antiaggregatory activity of prostacyclin by propranolol in human platelets.
    Callahan KS; Johnson AR; Campbell WB
    Circulation; 1985 Jun; 71(6):1237-46. PubMed ID: 2986877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of prostaglandin D2 with prostacyclin, carbacyclin and the hydantoin prostaglandin, BW245C, in guinea-pig platelets.
    Hamid S; Whittle BJ
    Br J Pharmacol; 1985 May; 85(1):285-90. PubMed ID: 2992652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro effects of ethanol on rabbit platelet aggregation, secretion of granule contents, and cyclic AMP levels in the presence of prostacyclin.
    Rand ML; Gross PL; Jakowec DM; Packham MA; Mustard JF
    Thromb Haemost; 1989 Apr; 61(2):254-8. PubMed ID: 2546284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of forskolin on platelet deaggregation and cyclic AMP generation.
    Kariya T; Morito F; Sakai T; Takahata K; Yamanaka M
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Oct; 331(1):119-21. PubMed ID: 2999615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of human platelet function by prostacyclin and thromboxane A2.
    Gorman RR
    Fed Proc; 1979 Jan; 38(1):83-8. PubMed ID: 215465
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.